Lorraine Christie Porter
Direttore/Membro del Consiglio presso TCB Newco Ltd.
Profilo
Lorraine Christie Porter was the founder of STATS Group Ltd., which was founded in 1998, where she held the title of Co-Managing Director.
Currently, she holds the position of Non-Executive Director at TCB Newco Ltd.
Posizioni attive di Lorraine Christie Porter
Società | Posizione | Inizio |
---|---|---|
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Lorraine Christie Porter
Società | Posizione | Fine |
---|---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Industrial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
- Borsa valori
- Insiders
- Lorraine Christie Porter